Asan Medical Center-Pediatrics - Pedicatric Oncology ( Site 4973)
Seoul 05505
1 studies enrolling now · 1 studies all time
What they study most
Malignant Neoplasm
Studies at this site
A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
— Recruiting now